Skip to main content
SpringerLink
Log in

Liver Steatosis (CAP) as Modifier of Liver Stiffness

  • Chapter
  • First Online:
Liver Elastography

Abstract

Liver stiffness (LS) is a tissue characteristic that reflects a combination of fibrosis stage, liver perfusion and inflammation, and is modulated by several technical confounders of the measurement technique. Liver steatosis results from metabolic alterations associated with diabetes mellitus and obesity. It is defined by the presence of lipid droplets within the hepatocytes which alter ultrasound propagation and physical tissue properties. This chapter focuses on the potential modulation of LS by steatosis and discusses noninvasive ultrasound-based methods of steatosis quantification as potential modifiers of LS interpretation. In summary, steatosis-induced modulation of liver stiffness remains a topic of ongoing debate. Although no specific recommendation can be given, most studies indicate a reduced diagnostic precision of LSM in patients with severe steatosis and obesity, which especially impairs the positive predictive value of LSM for ruling in advanced fibrosis. In some cohorts, steatosis is not at all or even slightly negatively correlated with LS. There are individual case observations, in the absence of inflammation, where a decrease of steatosis/CAP during alcohol detoxification leads to a slight elevation of LS. Future studies should prospectively analyze the effect of steatosis on LS in further detail.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. EASL-EASD-EASO Clinical EASL. Practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–402.

    Article  Google Scholar 

  2. Bedossa P, Biopsy PK. Noninvasive methods to assess progression of nonalcoholic fatty liver disease. Gastroenterology. 2016;150(8):1811–22.e4.

    Article  Google Scholar 

  3. Dyson JK, McPherson S, Anstee QM. Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. J Clin Pathol. 2013;66(12):1033–45.

    Article  CAS  Google Scholar 

  4. Hirche TO, Ignee A, Hirche H, Schneider A, Dietrich CF. Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection. Liver Int. 2007;27(6):748–57.

    Article  CAS  Google Scholar 

  5. Nightingale K, Rouze N, Rosenzweig S, Wang M, Abdelmalek M, Guy C, et al. Derivation and analysis of viscoelastic properties in human liver: impact of frequency on fibrosis and steatosis staging. IEEE Trans Ultrason Ferroelectr Freq Control. 2015;62(1):165–75.

    Article  Google Scholar 

  6. Shen F, Zheng RD, Shi JP, Mi YQ, Chen GF, Hu X, et al. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease. Liver Int. 2015;35(11):2392–400.

    Article  Google Scholar 

  7. Mueller S. Does pressure cause liver cirrhosis? The sinusoidal pressure hypothesis. World J Gastroenterol. 2016;22(48):10482.

    Article  Google Scholar 

  8. Mueller S, Nahon P, Rausch V, Peccerella T, Silva I, Yagmur E, et al. Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease. Hepatology. 2017;66(1):96–107.

    Article  CAS  Google Scholar 

  9. Rausch V, Peccerella T, Lackner C, Yagmur E, Seitz HK, Longerich T, et al. Primary liver injury and delayed resolution of liver stiffness after alcohol detoxification in heavy drinkers with the PNPLA3 variant I148M. World J Hepatol. 2016;8(35):1547–56.

    Article  Google Scholar 

  10. Ballestri S, Nascimbeni F, Lugari S, Lonardo A, Francica G. A critical appraisal of the use of ultrasound in hepatic steatosis. Expert Rev Gastroenterol Hepatol. 2019;13(7):667–81.

    Article  CAS  Google Scholar 

  11. Piscaglia F, Salvatore V, Mulazzani L, Cantisani V, Schiavone C. Ultrasound shear wave elastography for liver disease. a critical appraisal of the many actors on the stage. Eur J Ultrasound. 2016;37(01):1–5.

    CAS  Google Scholar 

  12. Berzigotti A. Getting closer to a point-of-care diagnostic assessment in patients with chronic liver disease: controlled attenuation parameter for steatosis. J Hepatol. 2014;60(5):910–2.

    Article  Google Scholar 

  13. Karlas T, Petroff D, Wiegand J. Collaboration, not competition: the role of magnetic resonance, transient elastography, and liver biopsy in the diagnosis of nonalcoholic fatty liver disease. Gastroenterology. 2017;152(3):479–81.

    Article  Google Scholar 

  14. Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a Novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36(11):1825–35.

    Article  Google Scholar 

  15. Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de Ledinghen V, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66(5):1022–30.

    Article  Google Scholar 

  16. Tada T, Iijima H, Kobayashi N, Yoshida M, Nishimura T, Kumada T, et al. Usefulness of attenuation imaging with an ultrasound scanner for the evaluation of hepatic steatosis. Ultrasound Med Biol. 2019;45(10):2679–87.

    Article  Google Scholar 

  17. Karlas T. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques. World J Gastroenterol. 2015;21(16):4894.

    Article  Google Scholar 

  18. Keller J, Kaltenbach TEM, Haenle MM, Oeztuerk S, Graeter T, Mason RA, et al. Comparison of Acoustic Structure Quantification (ASQ), shearwave elastography and histology in patients with diffuse hepatopathies. BMC Med Imaging. 2015;15(1).

    Google Scholar 

  19. Liu J, Ren W, Ai H, Dun G, Ji Y, Zhang Y, et al. Acoustic structure quantification versus point shear wave speed measurement for the assessment of liver fibrosis in viral hepatitis B. Ultrasound Med Biol. 2018;44(6):1177–86.

    Article  Google Scholar 

  20. Mueller S. Personal observation. 2019.

    Google Scholar 

  21. Poynard T, Pham T, Perazzo H, Munteanu M, Luckina E, Elaribi D, et al. Real-time shear wave versus transient elastography for predicting fibrosis: applicability, and impact of inflammation and steatosis. A non-invasive comparison. PLoS One. 2016;11(10):e0163276.

    Article  Google Scholar 

  22. Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013;57(3):1182–91.

    Article  Google Scholar 

  23. Macaluso FS, Maida M, Cammà C, Cabibbo G, Cabibi D, Alduino R, et al. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C. J Hepatol. 2014;61(3):523–9.

    Article  Google Scholar 

  24. Petta S, Maida M, Macaluso FS, Di Marco V, Camma C, Cabibi D, et al. The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease. Hepatology. 2015;62(4):1101–10.

    Article  Google Scholar 

  25. Karlas T, Dietrich A, Peter V, Wittekind C, Lichtinghagen R, Garnov N, et al. Evaluation of transient elastography, acoustic radiation force impulse imaging (ARFI), and enhanced liver function (ELF) score for detection of fibrosis in morbidly obese patients. PLoS One. 2015;10(11):e0141649.

    Article  Google Scholar 

  26. Harris N, Nadebaum D, Christie M, Gorelik A, Nicoll A, Sood S, et al. Acoustic radiation force impulse accuracy and the impact of hepatic steatosis on liver fibrosis staging. J Med Imaging Radiat Oncol. 2016;60(5):587–92.

    Article  Google Scholar 

  27. Conti F, Serra C, Vukotic R, Fiorini E, Felicani C, Mazzotta E, et al. Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C. Liver Int. 2016;37(2):187–95.

    Article  Google Scholar 

  28. Petta S, Wong VW, Camma C, Hiriart JB, Wong GL, Marra F, et al. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values. Hepatology. 2017;65(4):1145–55.

    Article  CAS  Google Scholar 

  29. Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de Ledinghen V, et al. Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement. Aliment Pharmacol Ther. 2018;47(7):989–1000.

    Article  CAS  Google Scholar 

  30. Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717–30.

    Article  Google Scholar 

  31. Shen F, Mi YQ, Xu L, Liu YG, Wang XY, Pan Q, et al. Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis. Aliment Pharmacol Ther. 2019;50(1):93–102.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Medical Department II, University of Leipzig Medical Center, Leipzig, Germany

    Thomas Karlas

  2. Department of Medicine and Center for Alcohol Research and Liver Diseases, Salem Medical Center, University of Heidelberg, Heidelberg, Germany

    Sebastian Mueller

Authors
  1. Thomas Karlas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sebastian Mueller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Karlas .

Editor information

Editors and Affiliations

  1. Department of Medicine and Center for Alcohol Research and Liver Diseases, Salem Medical Center, University of Heidelberg, Heidelberg, Germany

    Sebastian Mueller

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Karlas, T., Mueller, S. (2020). Liver Steatosis (CAP) as Modifier of Liver Stiffness. In: Mueller, S. (eds) Liver Elastography. Springer, Cham. https://doi.org/10.1007/978-3-030-40542-7_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-40542-7_39

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-40541-0

  • Online ISBN: 978-3-030-40542-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation